Facchini FS et al.: Am J Hypertens 1996 Oct; 9(10 Pt 1):1013-7
    Reaven GM : Physiol Rev 1995 Jul; 75(3):473-86
    Reaven GM : J Intern Med Suppl 1994; 736:13-22
    Nilsson PM et al.: J Hypertens 1994 Aug; 12(8):965-9
    Flack JM et al.: Am J Med 91: 11S-21S, 1991

X

1.
2.
3.
4.
5.
6.

Reaven GM : Physiol Rev 1995 Jul; 75(3):473-86
Reaven GM : J Intern Med Suppl 1994; 736:13-22



50% *.

, **.


***.


5 - ( , , )*.

*Yip J et al. J Clin Endocrinol Metab 1998 Aug; 83(8):2773-6


. , *,**.

**:


50% ***

* Reaven GM: Diabetes Care 1991 Nov; 14 Suppl 4:33-8
** Black HR: J Cardiovasc Pharmacol 1990; 15 Suppl 5:S26-38
*** Zavaroni I et al. J Intern Med 231: 235-240,1992

- ,
*.


** **


II * **

, -

(AUC )*

*

12-

(25 ) (20 ) *

Ѯ ͮ
10 : 1-2 3

20 : 1 2
- 12,5 3
50 3
10 : 1-2

20 : 1
12,5 - 25
- 6,5 3
1-2
- 37,5-75

 
Ѯ ͮ

A
+
  • 3


  • ,

    :
    X.

    :
    Ѯ ()
    , ( )
    10 20
  • 20 .
  • ͮ ()
    ( )
    12,5 25 50 100
  • .
  • ®